Table 3.
SNP | Oil | Controls (%) | Cases (%) | OR (95%CI)* | P value | |
---|---|---|---|---|---|---|
rs217727 | CC | Non-exposure | 86(32.3) | 59(22.0) | 1(ref) | |
CT + TT | Non-exposure | 114(42.9) | 109(40.7) | 1.373(0.898–2.098) | 0.143 | |
CC | Exposure | 27(10.2) | 36(13.4) | 1.921(1.055–3.501) | 0.033 | |
CT + TT | Exposure | 39(14.6) | 64(23.9) | 2.368(1.409–3.978) | 0.001 | |
rs2107425 | CC | Non-exposure | 70(26.3) | 43(16.0) | 1(ref) | |
CT + TT | Non-exposure | 130(48.9) | 125(46.6) | 1.550(0.985–2.439) | 0.058 | |
CC | Exposure | 25(9.4) | 29(10.8) | 1.852(0.960–3.575) | 0.066 | |
CT + TT | Exposure | 41(15.4) | 71(26.5) | 2.811(1.636–4.830) | < 0.001 | |
rs2735469 | CT + TT | Non-exposure | 18(6.8) | 10(3.7) | 1(ref) | |
CC | Non-exposure | 182(68.4) | 158(59.0) | 1.548(0.693–3.455) | 0.286 | |
CT + TT | Exposure | 9(3.4) | 7(2.6) | 1.388(0.395–4.876) | 0.609 | |
CC | Exposure | 57(21.4) | 93(34.7) | 2.906(1.253–6.744) | 0.013 | |
rs17658052 | GG | Non-exposure | 188(70.7) | 150(56.0) | 1(ref) | |
GA + AA | Non-exposure | 12(4.5) | 18 (6.7) | 1.900(0.887–4.073) | 0.099 | |
GG | Exposure | 62(23.3) | 94(35.1) | 1.897(1.289–2.792) | 0.001 | |
GA + AA | Exposure | 4(1.5) | 6(2.2) | 1.920(0.531–6.948) | 0.320 |
*: adjusted by age